Healthcare Technology IPOs: A Decade in Review
Over the past decade, the healthcare technology sector has experienced significant transformation, with numerous companies going public and reshaping traditional healthcare delivery and payment models. This essay examines healthcare technology IPOs from 2015 to 2024, analyzing business models and post-IPO performance with particular focus on whether successful companies operated within traditional healthcare systems or served as external vendors to these entities.
The Early Wave: 2015-2018
The first half of this period saw relatively modest IPO activity in health technology. Notable public offerings included Teladoc (2015), iRhythm Technologies (2016), and Livongo (2019). These companies represented the initial wave of digital health solutions gaining sufficient scale to warrant public market attention.
Teladoc established itself as a pioneer in telehealth services, providing virtual care directly to patients while contracting with insurance companies and employers. After going public at $19 per share, Teladoc saw steady growth until the COVID-19 pandemic catalyzed explosive expansion. However, post-pandemic performance has been challenged by competition and integration issues following its $18.5 billion acquisition of Livongo in 2020.
iRhythm Technologies, with its Zio cardiac monitoring platform, positioned itself as a technology provider to traditional healthcare providers rather than a direct care delivery entity. Its post-IPO performance demonstrated consistent revenue growth, though profitability remained elusive for several years.
The Digital Health Boom: 2019-2021
Continued…
treyrawles.substack.com…